Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,826 JPY | +0.71% | -0.91% | 0.00% |
May. 06 | Calliditas Therapeutics' Potential Head and Neck Cancer Treatment Meets Secondary Endpoints | MT |
May. 06 | UK Tribunal Greenlights GBP790 Million Lawsuit vs Prysmian, Nexans, NKT | MT |
Evolution of the average Target Price on Trial Holdings Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- 141A Stock
- Consensus Trial Holdings Inc.